FDA Import Refusal 8B4-0012228-7/80002/1E — GB PHARMA LTD
The FDA refused shipment 8B4-0012228-7/80002/1E from GB PHARMA LTD (United Kingdom) on June 29, 2026. The refused product falls under Drugs and Biologics — ACETAMINOPHEN (ANALGESIC). Cited charges: 118,3280,75
Refusal Details
- Date
- June 29, 2026
- Country
- United Kingdom
- Product Category
- Drugs and Biologics
- Product Code
- 60LDA01 ACETAMINOPHEN (ANALGESIC)
- Charges
- 118,3280,75